|
TNKS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.163600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.139800E-01 |
| Normal-vs-Stage2 |
6.426400E-01 |
| Normal-vs-Stage3 |
9.451400E-01 |
| Normal-vs-Stage4 |
8.948200E-01 |
| Stage1-vs-Stage2 |
3.684600E-01 |
| Stage1-vs-Stage3 |
6.189600E-01 |
| Stage1-vs-Stage4 |
5.043000E-01 |
| Stage2-vs-Stage3 |
7.248600E-01 |
| Stage2-vs-Stage4 |
7.281600E-01 |
| Stage3-vs-Stage4 |
9.628000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.547200E-01 |
| Normal-vs-AfricanAmerican |
7.127900E-02 |
| Normal-vs-Asian |
7.659000E-01 |
| Caucasian-vs-AfricanAmerican |
6.208400E-02 |
| Caucasian-vs-Asian |
7.092800E-01 |
| AfricanAmerican-vs-Asian |
4.782000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.736800E-01 |
| Normal-vs-Female |
8.222400E-01 |
| Male-vs-Female |
1.224760E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.705200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.591600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.492600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.301600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.561200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.562400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.071600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.705800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.007830E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.827000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.346500E-02 |
| Classical-VS-Follicular |
7.402000E-02 |
| Classical-VS-Other |
6.404800E-01 |
| Classical-VS-Normal |
2.820000E-01 |
| Tall-VS-Follicular |
9.609600E-01 |
| Tall-VS-Other |
6.256200E-01 |
| Tall-VS-Normal |
3.506000E-01 |
| Follicular-VS-Other |
7.953200E-01 |
| Follicular-VS-Normal |
4.349600E-01 |
| Other-VS-Normal |
9.759200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.683600E-01 |
| Normal-vs-N1 |
6.353800E-01 |
| N0-vs-N1 |
8.094200E-01 |
|
|
